Difficulty: Medium
Average Score: 90%
Practice
Tolerance to the antiparkinsonian action develops most rapidly in the case of
Correct answer
C
Rationale
In this case, the correct answer is C) Amantadine. Tolerance to the antiparkinsonian action develops most rapidly with amantadine compared to the other options.
Amantadine is an NMDA receptor antagonist that helps in managing Parkinson's disease symptoms. However, the development of tolerance can occur relatively quickly with amantadine, requiring dose adjustments or alternative treatment strategies.
Levodopa (options A and B) is a common medication for Parkinson's disease, but tolerance does not develop as rapidly as with amantadine. Levodopa is typically combined with carbidopa to enhance its effectiveness and reduce side effects.
Bromocriptine (option D) is a dopamine agonist used in Parkinson's disease treatment. Tolerance to bromocriptine may develop over time, but it is not as rapid as with amantadine.
In an educational context, understanding the concept of tolerance in pharmacology is crucial for healthcare professionals managing patients with Parkinson's disease. It is essential to monitor patients for tolerance development to adjust treatment plans effectively and ensure optimal symptom management. Educating healthcare providers about the differences in tolerance development among various CNS drugs is vital for improving patient outcomes and quality of life.
Amantadine is an NMDA receptor antagonist that helps in managing Parkinson's disease symptoms. However, the development of tolerance can occur relatively quickly with amantadine, requiring dose adjustments or alternative treatment strategies.
Levodopa (options A and B) is a common medication for Parkinson's disease, but tolerance does not develop as rapidly as with amantadine. Levodopa is typically combined with carbidopa to enhance its effectiveness and reduce side effects.
Bromocriptine (option D) is a dopamine agonist used in Parkinson's disease treatment. Tolerance to bromocriptine may develop over time, but it is not as rapid as with amantadine.
In an educational context, understanding the concept of tolerance in pharmacology is crucial for healthcare professionals managing patients with Parkinson's disease. It is essential to monitor patients for tolerance development to adjust treatment plans effectively and ensure optimal symptom management. Educating healthcare providers about the differences in tolerance development among various CNS drugs is vital for improving patient outcomes and quality of life.